Please assess the completion status of the following clinical trial:

Trial Title: Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: None
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: None
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Inclusion criteria will include all HCA hospitals that reside in US states where physicians do NOT routinely prescribe decolonization for MRSA + ICU patients.~Exclusion Criteria:~* Exclusion criteria will include hospitals where ICU physicians often prescribe decolonization for MRSA+ ICU patients.~* Dedicated burn ICUs will also be excluded due to the inability to perform routine bathing.~* Finally, since the intent is to assess the intervention in adult ICUs, pediatric hospitals will be excluded although patients \<13 years old that are admitted to participating adult ICUs will be included in the unit-based intervention.

- Gender: ALL
- Minimum Age: 13 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm 1: Usual Care-Active Surveillance (Type: NO_INTERVENTION): Active Surveillance in All Adult ICUs, Contact Precautions for MRSA+
- Arm 2: Targeted Decolonization (Type: ACTIVE_COMPARATOR): Continue Active Surveillance (AS), MRSA decolonization based on AS, Continue Contact Precautions for MRSA+
- Arm 3: Universal Decolonization (Type: ACTIVE_COMPARATOR): Chlorhexidine bath and nasal mupirocin for all, Discontinuation of Active Surveillance, Continuation of Contact Precautions for MRSA+

Based on this trial design, predict the completion outcome and termination type (if applicable).